Results for technologies (1)
Advanced filter
Optimized MAGE-A1 targeting TCR for T-cell Therapy (No. T4-1662)
Using affinity maturated TCRs to generate reactive T cells
Immunotherapy, that is the use of the immune system to treat cancer, is currently a leading candidate in the combat against cancer.
This technology presents a new method of increasing the affinity of a TCR to i...
Read more
5572